Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis

Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis

Abstract Background Currently, there is no standard treatment for managing relapse in patients with acute myeloid leukemia and myelodysplastic syndrome (AML/MDS) after allogeneic hematopoietic cell transplantation. Venetoclax-based therapies have been increasingly used for treating post-transplantat...

Full description

Bibliographic Details
Main Authors: Yufeng Du, Chunhong Li, Zhijia Zhao, Yikun Liu, Chengtao Zhang, Jinsong Yan
Format: Article
Language:English
Published: BMC 2023-08-01
Series:BMC Cancer
Subjects:
Acute myeloid leukemia
Myelodysplastic syndrome
Venetoclax
Hypomethylating agents
Allogeneic hematopoietic cell transplantation
Relapse
Online Access:https://doi.org/10.1186/s12885-023-11259-6

Internet

https://doi.org/10.1186/s12885-023-11259-6

Similar Items